Biocompatibility of Carbon Nanotubes for Cartilage Tissue Engineering

被引:0
|
作者
Chahine, Nadeen O. [1 ]
Collette, Nicole M. [2 ]
Thompson, Heather [1 ]
Loots, Gabriela G. [1 ,2 ]
机构
[1] Lawrence Livermore Natl Lab, Livermore, CA USA
[2] Univ Calif Berkeley, Berkeley, CA 94720 USA
关键词
Carbon Nanotubes; Cytotoxicity; Tissue Engineering; Biocompatibility; Cartilage;
D O I
暂无
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Carbon nanotubes (CNT) have the potential to become an important component of scaffolding in tissue engineering, due to their unique physical properties. However, one major limitation of CNTs that must be overcome is their inherent cytotoxicity. In this study, we assessed the long-term biocompatibility of CNTs for chondrocyte growth. The effect of CNTs on chondrocyte viability and biochemical deposition has been examined in two dimensional (2D) cultures, and in three dimensional (3D) composite materials consisting of hydrogels and CNTs. The exposure of chondrocytes to CNTs was carried out up to 14 days in 2D culture and 21 days in 3D agarose composites. Our results suggest that functionalized CNTs alter the viability and metabolic response of cells over the 2 to 3 week duration. Interestingly, the results of this study also suggest the dose dependent effect of CNTs on cellular responses vary between 2D and 3D cultures, suggesting that chondrocytes tolerate the presence of CNTs at greater concentrations in 3D more than in 2D cultures. In addition, CNTs appear to have a stimulatory metabolic effect on chondrocytes in 3D cultures, reflected by enhanced production of glycosaminoglycans (GAGS) and collagen deposition. These findings support the notion that optimization of the use of nanotubes in cell-based therapies should be performed in 3D systems directly, and that CNTs appear to promote cellular growth and metabolic activity of chondrocytes.
引用
收藏
页码:125 / +
页数:2
相关论文
共 50 条
  • [41] Bioreactors for Tissue Engineering of Cartilage
    Concaro, S.
    Gustavson, F.
    Gatenholm, P.
    [J]. BIOREACTOR SYSTEMS FOR TISSUE ENGINEERING, 2009, 112 : 125 - 143
  • [42] BIOREACTOR FOR CARTILAGE TISSUE ENGINEERING
    Mikulenka, Petr
    Franta, Lukas
    Daniel, Matej
    [J]. 25TH DANUBIA-ADRIA SYMPOSIUM ON ADVANCES IN EXPERIMENTAL MECHANICS, 2008, : 173 - 174
  • [43] Biomechanics in cartilage tissue engineering
    Zhang C.
    Li K.
    Gao L.
    Zhang X.
    [J]. Advances in Mechanics, 2018, 48 (01) : 410 - 437
  • [44] Perspectives on cartilage tissue engineering
    Schneider, U
    [J]. AKTUELLE RHEUMATOLOGIE, 2003, 28 (06) : 322 - 327
  • [45] Tissue engineering: chondrocytes and cartilage
    Hardingham, Tim
    Tew, Simon
    Murdoch, Alan
    [J]. ARTHRITIS RESEARCH & THERAPY, 2002, 4 (Suppl 3) : S63 - S68
  • [46] Tissue engineering of cartilage in space
    Freed, LE
    Langer, R
    Martin, I
    Pellis, NR
    VunjakNovakovic, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) : 13885 - 13890
  • [47] Articular Cartilage Tissue Engineering
    Athanasiou, Kyriacos A.
    Darling, Eric M.
    Hu, Jerry C.
    [J]. Synthesis Lectures on Tissue Engineering, 2010, 1 (01): : 1 - 182
  • [48] In vivo cartilage tissue engineering
    Gurer, B.
    Cabuk, S.
    Karakus, O.
    Yilmaz, N.
    Yilmaz, C.
    [J]. JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2018, 13
  • [49] An overview of cartilage tissue engineering
    Kim, HW
    Han, CD
    [J]. YONSEI MEDICAL JOURNAL, 2000, 41 (06) : 766 - 773
  • [50] Tissue engineering of meniscal cartilage
    Neves, AA
    Medcalf, N
    Brindle, KM
    [J]. ANIMAL CELL TECHNOLOGY: FROM TARGET TO MARKET, 2001, 1 : 571 - 573